We found that there was great clinical value in the SH3RF1 gene and that it could act as a new diagnostic biomarker and indicator to evaluate survival and prognosis of LKB1 mutant lung adenocarcinoma patients. The gene discussed is STK11; the disease is lung adenocarcinoma.